DAUNORUBICIN

Basic Information

Item Value
DrugBank ID DB00694
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 138

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 acute promyelocytic leukemia TxGNN Knowledge Graph
2 therapy related acute myeloid leukemia and myelodysplastic syndrome TxGNN Knowledge Graph
3 acute myeloid leukemia with CEBPA somatic mutations TxGNN Knowledge Graph
4 acute myeloid leukemia with t(8;21)(q22;q22) translocation TxGNN Knowledge Graph
5 acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor TxGNN Knowledge Graph
6 leukemia, lymphocytic, susceptibility to TxGNN Knowledge Graph
7 acute myeloblastic leukemia with maturation TxGNN Knowledge Graph
8 precursor T-cell acute lymphoblastic leukemia TxGNN Knowledge Graph
9 unclassified acute myeloid leukemia TxGNN Knowledge Graph
10 acute lymphoblastic/lymphocytic leukemia TxGNN Knowledge Graph
11 inherited acute myeloid leukemia TxGNN Knowledge Graph
12 acute myeloid leukemia with t(9;11)(p22;q23) TxGNN Knowledge Graph
13 Kaposi’s sarcoma (disease) TxGNN Knowledge Graph
14 acute myeloid leukemia with minimal differentiation TxGNN Knowledge Graph
15 acute lymphoblastic leukemia (disease) TxGNN Knowledge Graph
16 monocytic leukemia TxGNN Knowledge Graph
17 acute myeloid leukemia with t(8;16)(p11;p13) translocation TxGNN Knowledge Graph
18 acute erythroid leukemia TxGNN Knowledge Graph
19 acute myeloblastic leukemia without maturation TxGNN Knowledge Graph
20 acute myeloid leukemia with t(6;9)(p23;q34) TxGNN Knowledge Graph
21 acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2) TxGNN Knowledge Graph
22 acute myeloid leukemia with NPM1 somatic mutations TxGNN Knowledge Graph
23 myeloid leukemia TxGNN Knowledge Graph
24 acute promyelocytic leukemia TxGNN Knowledge Graph
25 therapy related acute myeloid leukemia and myelodysplastic syndrome TxGNN Knowledge Graph
26 acute myeloid leukemia with CEBPA somatic mutations TxGNN Knowledge Graph
27 acute myeloid leukemia with t(8;21)(q22;q22) translocation TxGNN Knowledge Graph
28 acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor TxGNN Knowledge Graph
29 leukemia, lymphocytic, susceptibility to TxGNN Knowledge Graph
30 acute myeloblastic leukemia with maturation TxGNN Knowledge Graph
31 precursor T-cell acute lymphoblastic leukemia TxGNN Knowledge Graph
32 unclassified acute myeloid leukemia TxGNN Knowledge Graph
33 acute lymphoblastic/lymphocytic leukemia TxGNN Knowledge Graph
34 inherited acute myeloid leukemia TxGNN Knowledge Graph
35 acute myeloid leukemia with t(9;11)(p22;q23) TxGNN Knowledge Graph
36 Kaposi’s sarcoma (disease) TxGNN Knowledge Graph
37 acute myeloid leukemia with minimal differentiation TxGNN Knowledge Graph
38 acute lymphoblastic leukemia (disease) TxGNN Knowledge Graph
39 monocytic leukemia TxGNN Knowledge Graph
40 acute myeloid leukemia with t(8;16)(p11;p13) translocation TxGNN Knowledge Graph
41 acute erythroid leukemia TxGNN Knowledge Graph
42 acute myeloblastic leukemia without maturation TxGNN Knowledge Graph
43 acute myeloid leukemia with t(6;9)(p23;q34) TxGNN Knowledge Graph
44 acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2) TxGNN Knowledge Graph
45 acute myeloid leukemia with NPM1 somatic mutations TxGNN Knowledge Graph
46 myeloid leukemia TxGNN Knowledge Graph
47 acute promyelocytic leukemia TxGNN Knowledge Graph
48 therapy related acute myeloid leukemia and myelodysplastic syndrome TxGNN Knowledge Graph
49 acute myeloid leukemia with CEBPA somatic mutations TxGNN Knowledge Graph
50 acute myeloid leukemia with t(8;21)(q22;q22) translocation TxGNN Knowledge Graph

(Showing top 50 of 138 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search